Nasdaq:US$13.50 (+0.55) | HKEX:HK$22.25 (+0.45) | AIM:£2.26 (+0.09)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 18 Jun 2007

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility

1 items
a070618